| Financial Year |
March 31 2023 |
| Monetary Funds |
8,896,624,294.93 |
| Held-for-trading Financial Assets |
685,373,957.13 |
| Notes Receivable |
21,551,852.00 |
| Accounts Receivable |
1,645,250,973.87 |
| Advances to Suppliers |
300,659,268.96 |
| Other Receivables |
130,439,133.03 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,125,729,030.08 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
3,191,602,143.75 |
| Other Current Assets |
176,379,752.09 |
| Total Current Assets |
18,193,807,147.93 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
29,351,660,380.30 |
| Long-term Equity Investment |
24,991,069,895.02 |
| Investment Properties |
102,148,506.78 |
| Fixed Assetes |
42,957,635,256.33 |
| Under-construction Projects |
306,084,514.64 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
615,090,386.91 |
| R&D expenses |
29,918,985.23 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,089,319.62 |
| Deferred Income Tax Assets |
116,194,616.00 |
| Other Non-Current Assets |
414,702,218.25 |
| Sub-Total of Non-Current Assets |
101,783,236,739.79 |
| Total Assets |
119,977,043,887.72 |
| Short-Term Loans |
12,728,719,557.50 |
| Trading Financial liabilities |
-- |
| Notes Payable |
40,121,668.27 |
| Accounts Payable |
2,281,149,321.74 |
| Accounts Received In Advance |
496,043,372.31 |
| Employee Compensation Payable |
585,635,900.08 |
| Taxes Payable |
320,534,809.50 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,047,504,516.19 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
13,066,537,191.54 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
30,874,690,841.47 |
| Long-term Loans |
51,423,744,498.36 |
| Bonds Payable |
8,000,000,000.00 |
| Long-Term Accounts Payable |
578,440,814.71 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
6,557,202.92 |
| Other Non-Current Liabilities |
808,091.35 |
| Sub-Total of Non-Current Liabilities |
60,113,837,521.67 |
| Total Liabilities |
90,988,528,363.14 |
| Paid-In Capital(Or Share Stock) |
13,573,299,906.00 |
| Capital Surplus |
2,488,963,988.14 |
| Surplus Reserve |
2,354,166,698.70 |
| LESS:Treasury Stock |
134,525,049.76 |
| Undistributed Profits |
13,051,908,629.94 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
28,988,515,524.58 |
| Owner's Equity（Stockholder's Equity） |
28,988,515,524.58 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
119,977,043,887.72 |
